Dong-Hua Yang Selected Research

CCTA-1523

7/2017

Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Hua Yang Research Topics

Disease

64	Neoplasms (Cancer) 11/2022 - 05/2002
7	Carcinoma (Carcinomatosis) 01/2020 - 10/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2014
6	Hepatocellular Carcinoma (Hepatoma) 05/2017 - 04/2000
4	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2012
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
4	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2002
3	Colonic Neoplasms (Colon Cancer) 07/2021 - 08/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2022 - 03/2017
2	Triple Negative Breast Neoplasms 12/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
2	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 01/2017
2	Adenocarcinoma 07/2017 - 01/2016
2	Carcinogenesis 01/2013 - 06/2004
2	Cysts 12/2003 - 10/2002
1	Reperfusion Injury 06/2022
1	Myocardial Infarction 06/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Pathologic Complete Response 01/2022
1	Liver Neoplasms (Liver Cancer) 04/2021
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Malaria 12/2020
1	COVID-19 12/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2020
1	Cardiotoxicity 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 07/2021 - 01/2013
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2002
10	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2020 - 01/2016
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2021 - 04/2011
6	Adenosine Triphosphate (ATP)IBA 07/2020 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 05/2014
4	Topotecan (Hycamtin)FDA LinkGeneric 01/2021 - 06/2014
4	Antineoplastic Agents (Antineoplastics)IBA 07/2020 - 01/2018
3	oridoninIBA 01/2020 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2013
2	EnzymesIBA 01/2022 - 11/2018
2	venetoclaxIBA 01/2022 - 02/2020
2	Biological ProductsIBA 07/2021 - 05/2010
2	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2021 - 11/2020
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 07/2017
2	Messenger RNA (mRNA)IBA 05/2017 - 06/2004
2	CholesterolIBA 09/2015 - 01/2013
2	SterolsIBA 09/2015 - 01/2013
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2012 - 04/2011
2	Phosphodiesterase 5 InhibitorsIBA 08/2012 - 04/2011
2	Single-Chain AntibodiesIBA 05/2010 - 01/2001
2	Laminin (Merosin)IBA 10/2002 - 05/2002
2	CollagenIBA 10/2002 - 05/2002
1	InflammasomesIBA 06/2022
1	geniposideIBA 06/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	evodiamineIBA 12/2021
1	CurcuminIBA 07/2021
1	TubulinIBA 04/2021
1	Phosphates (Orthophosphate)IBA 04/2021
1	Tramadol (K315)FDA LinkGeneric 01/2021
1	OTS964IBA 01/2021
1	cabozantinibIBA 01/2021
1	alectinibIBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	Tripartite Motif ProteinsIBA 01/2021
1	SurvivinIBA 01/2021
1	Proteolysis Targeting ChimeraIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Dexmedetomidine FDA Link 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020
1	Chloroquine (Aralen)FDA LinkGeneric 12/2020
1	HM781-36BIBA 11/2020
1	FlavonoidsIBA 08/2020
1	QuercetinIBA 08/2020
1	WYE-354IBA 02/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	ARQ 197IBA 01/2020
1	Netrin ReceptorsIBA 01/2020
1	Antimicrobial PeptidesIBA 01/2020
1	AZ-628IBA 01/2020
1	Proto-Oncogene Proteins A-rafIBA 01/2020
1	IntegrinsIBA 01/2020

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2022 - 04/2011
13	Therapeutics 11/2022 - 12/2013
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 01/2017
1	Aftercare (After-Treatment) 01/2022
1	Analgesia 01/2021
1	Transplantation 01/2021